FIELD: pharmaceutical industry.
SUBSTANCE: invention relates to pharmaceuticals, namely to drugs based on sorafenib tosylate and methods for their preparation. A method for preparing a tablet based on sorafenib tosylate by mixing sorafenib tosylate with mannitol and auxiliary substances is proposed, in which the powder of sorafenib tosylate is treated in the absence of water with mannitol powder at a ratio of sorafenib tosylate: lures from 1: 1 to 1: 7 (optimally 1: 2), after which sodium croscarmellose and sodium lauryl sulfate are added to the resulting mixture, mixed, sodium stearyl fumarate is added, pressed and coated. A tablet based on sorafenib tosylate contains mannitol, sodium stearyl fumarate and colloidal silicon dioxide as a filler in the following ratio of ingredients (wt%): sorafenib tosylate from 10 to 40; mannitol from 40 to 70; colloidal silicon dioxide from 1.0 to 4.0; sodium stearyl fumarate - 0.5-5; sodium croscarmellose - 9-20; sodium lauryl sulfate.
EFFECT: invention performs its functions effectively.
3 cl, 3 ex, 1 tbl
Title |
Year |
Author |
Number |
IMMEDIATE RELEASE PHARMACEUTICAL COMPOSITIONS CONTAINING KETOPROFEN LYSINE SALT |
2019 |
- Cantarini, Marco
- Gentile, Marco Maria
- Prota, Lucia
|
RU2804350C2 |
PHARMACEUTICAL COMPOSITIONS CONTAINING DORAVIRINE, TENOFOVIR DISOPROXIL FUMARATE AND LAMIVUDINE |
2016 |
- Panmai, Santipharp
- Tatavarti, Aditya
- Farrington, Andrew, M.
- Biyyala, Varsha
- Allain, Leonardo, R.
- Nefliu, Marcela
- Klinzing, Gerard, R.
- Ren, Jie
- Lamm, Matthew
|
RU2736941C2 |
PHARMACEUTICAL COMPOSITION CONTAINING A PYRROLE-CONDENSED SIX-MEMBERED HETEROCYCLIC COMPOUND |
2017 |
- Lu, Yun
- Zhang, Xinhua
- Wang, Chenyang
- Liu, Tonghui
|
RU2737734C2 |
PHARMACEUTICAL COMPOSITION FOR TREATING ARTERIAL HYPERTENSION AND CONGESTIVE CARDIAC FAILURE AND METHOD FOR PREPARING IT |
2011 |
- Emshanova Svetlana Vital'Evna
- Jurchenko Nikolaj Ivanovich
- Lashcheva Ol'Ga Jur'Evna
- Veselova Nina Ivanovna
- Goncharova Natal'Ja Viktorovna
- Ivanova Margarita Evgen'Evna
|
RU2479310C2 |
AMORPHOUS FORM OF 4-{4-[({[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]AMINO}CARBONYL)-AMINO]PHENOXY}-N-METHYLPYRIDINE-2-CARBOXAMIDE TOSYLATE (VERSIONS), METHOD FOR PRODUCTION AND USE THEREOF FOR TREATMENT OF ONCOLOGICAL DISEASES |
2020 |
- Torchinov Georgij Yur'Evich
|
RU2766288C2 |
DOSAGE FORM IN CAPSULE FORM CONTAINING TABLETS WITH DIMETHYL FUMARATE |
2019 |
- Ryzhakova Evgeniya Nikolaevna
- Shilov Maksim Sergeevich
- Lavrentev Viktor Vyacheslavovich
|
RU2742745C1 |
PHARMACEUTICAL COMPOSITION CONTAINING N-[3-CHLOR-4-[(3-FLUOROPHENYL)METHOXY]PHENYL]-6-[5[[[2-(METHYLSULPHONYL)ETHYL]AMINO]METHYL]-2-FURYL]-4-QUINAZOLINAMINE |
2009 |
- Katrin Rimkus
- Frank Muskulus
- Zandra Brjuk
- Jana Pehtts
|
RU2548757C2 |
SOLID PHARMACEUTICAL COMPOSITION CONTAINING 1-(3-(2-(1-BENZOTHIOPHENE-5-YL)ETOXY)PROPYL)AZETIDINE-3-OL OR ITS SALT |
2013 |
- Inaba Khiroyuki
- Nagata Mitsukhiro
|
RU2625767C2 |
PHARMACEUTICAL COMPOSITION FOR TREATING HIV INFECTION, METHOD FOR PREPARING IT, AND METHOD OF TREATING |
2012 |
- Batjunin Gennadij Andreevich
- Malykh Natal'Ja Jur'Evna
- Punija Vikram Singkh
|
RU2505286C1 |
PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF CYSTIC FIBRIOSIS |
2019 |
- Chu, Cathy
- Dhamankar, Varsha
- Dokou, Eleni
- Haseltine, Eric L.
- Moskowitz, Samuel
- Robertson, Sarah
- Waltz, David
- Chen, Weichao George
|
RU2822220C2 |